Talus Bio

Seattle, United States

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

$11.2M raised

Aug 2024

Seed

Top Investors

National Science FoundationY CombinatorPioneer FundFifty YearsNFX

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Talus Bio raised?

Talus Bio has raised $11.2M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Who are Talus Bio's investors?

Talus Bio's investors include National Science Foundation, Y Combinator, Pioneer Fund, Fifty Years, NFX.

Where is Talus Bio headquartered?

Talus Bio is headquartered in Seattle, United States.

What does Talus Bio do?

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

What stage is Talus Bio at?

Talus Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 20, 2024.

MLA

"Talus Bio — Funding & Investors." VCBacked, August 20, 2024, https://www.vcbacked.co/company/talus-bio. Accessed June 4, 2026.

APA

VCBacked. (2024). Talus Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/talus-bio

Wikipedia (cite web)

{{cite web |title=Talus Bio — Funding & Investors |url=https://www.vcbacked.co/company/talus-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 20, 2024.